|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61K 39/12 | |||
| C07K 16/28 | |||
| A61P 31/12 | |||
| A61P 31/18 | |||
| A61P 35/00 |
| (11) | Number of the document | 3064220 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16160525.8 |
| Date of filing the European patent application | 2007-12-26 | |
| (97) | Date of publication of the European application | 2016-09-07 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 877518 P | 2006-12-27 | US |
| (72) |
Ahmed, Rafi, US
Freeman, Gordon, US
Sharpe, Arlene, US
Amara, Rama, US
|
| (73) |
President and Fellows of Harvard College,
17 Quincy Street, Cambridge, MA 02138,
US
Dana-Farber Cancer Institute, Inc., 450 Brookline Avenue, Boston, MA 02215, US Emory University, 1599 Clifton Road, NE Fourth Floor, Atlanta, GA 30322, US |
| (54) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS |
| COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFECTIONS AND TUMORS |